Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study

BACKGROUND: Patients with impaired liver function (ILF) were excluded from clinical trials that investigated non–vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in patients with atrial fibrillation. The aim of this study was to evaluate the efficacy and safety of NOACs in atri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Wang, Chun‐Li, Wu, Victor Chien‐Chia, Kuo, Chang‐Fu, Chu, Pao‐Hsien, Tseng, Hsiao‐Jung, Wen, Ming‐Shien, Chang, Shang‐Hung
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201449/
https://ncbi.nlm.nih.gov/pubmed/30371232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.009263
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados